COMMUNIQUÉS West-GlobeNewswire

-
On “Grindeks” results in the first nine months of 2017
27/11/2017 -
NewLink Genetics to Participate in Upcoming Investor Conference
27/11/2017 -
Medtronic Launches New Telehealth Solutions in Support of U.S. Department of Veterans Affairs National Contract
27/11/2017 -
OrthoPediatrics Corp. to Highlight its Products at the 14th Annual International Pediatric Orthopaedic Symposium
27/11/2017 -
Arbutus Announces Presentations at HepDART 2017
27/11/2017 -
Analogic Celebrates 50 Years of Imaging Innovation at RSNA 2017
27/11/2017 -
Canada House Wellness Group Announces Extension of Closing Date for Convertible Debenture Unit Financing
27/11/2017 -
UroGen Pharma Announces Oral Presentation at Society of Urologic Oncology (SUO) Annual Meeting
27/11/2017 -
3D Signatures Inc. Announces Non-Brokered Private Placement to Raise $1,500,000 and Updates Previously Announced Brokered Private Placement
27/11/2017 -
T2 Biosystems to Attend the Global Mizuho Investor Conference
27/11/2017 -
Eloxx Pharmaceuticals Announces First Patient Dosed in Phase 1b Clinical Trial
27/11/2017 -
PositiveID Corporation to Present at the LD MICRO “Main Event” Investor Conference on December 6th
27/11/2017 -
iCAD’s PowerLook® Tomo Detection Experiences Growing Adoption
27/11/2017 -
Inovio Pharmaceuticals SynCon® TERT Cancer Immunotherapy Combined with Checkpoint Inhibitor Synergistically Shrinks Tumor and Improves Survival in Preclinical Tumor Model
27/11/2017 -
Golden Leaf Secures Cultivation License From Health Canada For State-of-the-Art Ontario Grow Facility
27/11/2017 -
Cancer Genetics Appoints Renowned Biotech Entrepreneur Dr. Thomas F. Widmann to its Board of Directors
27/11/2017 -
Intra-Cellular Therapies to Participate at the 29th Annual Piper Jaffray Healthcare Conference
27/11/2017 -
Medovex Corporation Submits IDE with the Food and Drug Administration for its DenerveX System
27/11/2017 -
aTyr Pharma Doses First Subjects in Phase 1 Trial of iMod.Fc (ATYR1923)
27/11/2017
Pages